Stephan Grissmer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stephan Grissmer has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Heiko Rauer
Department of Physiology and Biophysics, University of California, Irvine 92697-4560, USA
2 shared publicationsAngela N. Nguyen
Department of Physiology and Biophysics, University of California, Irvine, CA 92717, USA
1 shared publication- Deborah J. Morris-Rosendahl
Clinical Genetics and Genomics Laboratory, Royal Brompton Hospital, London, UK
1 shared publication Faiqa Imtiaz
Department of Applied Physiology University of Ulm Ulm Germany
1 shared publicationFrank Lehmann-Horn
Department of Applied Physiology University of Ulm Ulm Germany
1 shared publicationHeike Jäger
Department of Applied Physiology, University Ulm, Albert Einstein Allee 11, 89081 Ulm, Germany
1 shared publication
Latest Publications
- Open Access
- 1 March 2004
- Published by Elsevier in Molecular Pharmacology
- Vol. 65 (3) , 788-801
An Apamin- and Scyllatoxin-Insensitive Isoform of the Human SK3 Channel
We have isolated an hSK3 isoform from a human embryonic cDNA library that we have named hSK3_ex4. This isoform contains a 15 amino acid insertion within the S5 to P-loop segment. Transcripts encoding hSK3_ex4 are coexpressed at lower levels with hSK3 in neuronal as well as in non-neuronal tissues. To investigate the pharmacokinetic properties of hSK3_ex4, we expressed the isoforms hSK3 and hSK3_ex4 in tsA cells. Both isoforms were similarly activated by cytosolic Ca2+ (hSK3, EC50 = 0.91 ± 0.4 μM; hSK3_ex4, EC50 = 0.78 ± 0.2 μM) and by 1-ethyl-2-benzimidazolinone (hSK3, EC50 = 0.17 mM; hSK3_ex4, 0.19 mM). They were both blocked by tetraethylammonium (hSK3, Kd = 2.2 mM; hSK3_ex4, 2.6 mM) and showed similar permeabilities relative to K+ for Cs+ (hSK3, 0.17 ± 0.04, n = 3; hSK3_ex4, 0.17 ± 0.05, n = 3) and Rb+ (hSK3, 0.79 ± 0.04, n = 3; hSK3_ex4, 0.8 ± 0.07, n = 3). Ba2+ blocked both isoforms, and in both cases, the block was strongest at hyperpolarizing membrane potentials. However, the voltage-dependence of hSK3 was stronger than that of hSK3_ex4. The most obvious distinguishing feature of this new isoform was that whereas hSK3 was blocked by apamin (Kd = 0.8 nM), scyllatoxin (Kd = 2.1 nM), and d-tubocurarine (Kd = 33.4 μM), hSK3_ex4 was not affected by apamin up to 100 nM, scyllatoxin up to 500 nM, and d-tubocurarine up to 500 μM. So far, isoform hSK3_ex4 forms the only small-conductance calcium-activated potassium (SK) channels, which are insensitive to the classic SK blockers.
- 1 March 2004
- Published by Elsevier in Molecular Pharmacology
- Vol. 65 (3) , 788-801
Open AccessAn Apamin- and Scyllatoxin-Insensitive Isoform of the Human SK3 Channel
We have isolated an hSK3 isoform from a human embryonic cDNA library that we have named hSK3_ex4. This isoform contains a 15 amino acid insertion within the S5 to P-loop segment. Transcripts encoding hSK3_ex4 are coexpressed at lower levels with hSK3 in neuronal as well as in non-neuronal tissues. To investigate the pharmacokinetic properties of hSK3_ex4, we expressed the isoforms hSK3 and hSK3_ex4 in tsA cells. Both isoforms were similarly activated by cytosolic Ca2+ (hSK3, EC50 = 0.91 ± 0.4 μM; hSK3_ex4, EC50 = 0.78 ± 0.2 μM) and by 1-ethyl-2-benzimidazolinone (hSK3, EC50 = 0.17 mM; hSK3_ex4, 0.19 mM). They were both blocked by tetraethylammonium (hSK3, Kd = 2.2 mM; hSK3_ex4, 2.6 mM) and showed similar permeabilities relative to K+ for Cs+ (hSK3, 0.17 ± 0.04, n = 3; hSK3_ex4, 0.17 ± 0.05, n = 3) and Rb+ (hSK3, 0.79 ± 0.04, n = 3; hSK3_ex4, 0.8 ± 0.07, n = 3). Ba2+ blocked both isoforms, and in both cases, the block was strongest at hyperpolarizing membrane potentials. However, the voltage-dependence of hSK3 was stronger than that of hSK3_ex4. The most obvious distinguishing feature of this new isoform was that whereas hSK3 was blocked by apamin (Kd = 0.8 nM), scyllatoxin (Kd = 2.1 nM), and d-tubocurarine (Kd = 33.4 μM), hSK3_ex4 was not affected by apamin up to 100 nM, scyllatoxin up to 500 nM, and d-tubocurarine up to 500 μM. So far, isoform hSK3_ex4 forms the only small-conductance calcium-activated potassium (SK) channels, which are insensitive to the classic SK blockers.
- 1 December 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (7) , 1275-1284
Block of the lymphocyte K+ channel mKv1.3 by the phenylalkylamine verapamil: Kinetic aspects of block and disruption of accumulation of block by a single point mutation
Phenylalkylamines (PAA) usually known for their action on L‐type Ca2+ channels potently block the C‐type inactivating lymphocyte Kv1.3 channel resulting in inhibition of activation of T lymphocytes. In order to design PAAs blocking Kv1.3 specifically over L‐type Ca2+ channels, we investigated the state‐dependent manner of mKv1.3 block by the PAA verapamil. Verapamil seems to have access to the open state (OB) and, once bound to the channel, the channel‐verapamil complex is absorbed into a slowly recovering state. This state was proposed to be the inactivated blocked state (IB). Here we present a quantitative description of the transition into this state and provide evidence for the IB state through experiments with an inactivation lacking mutant channel. Since the inactivated state cannot be reached in this case the IB state cannot be reached either. We show that the transition OB→IB is accelerated by verapamil most likely through a mechanism involving the reduction of [K+] at an inactivation modulating low affinity binding site for K+ at the outer vestibule. Measurements of the voltage‐dependence of the off‐rate constants for verapamil suggest that verapamil can reach the channel in its neutral form and might get partially protonated while bound. Thus only those verapamil molecules that are protonated can more easily dissociate at hyperpolarizing voltages. Since open block kinetics were shown to be similar for wild type mKv1.3 and the H404T mutant mKv1.3 channel, and since the block of the H404T mutant channels by verapamil could be described exactly by a simple three‐state open block model, the mutant channel could serve as a screening channel to determine open block affinities of new PAA derivatives in high through‐put experiments. British Journal of Pharmacology (2000) 131, 1275–1284; doi:10.1038/sj.bjp.0703723
- 1 December 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (7) , 1275-1284
Block of the lymphocyte K+ channel mKv1.3 by the phenylalkylamine verapamil: Kinetic aspects of block and disruption of accumulation of block by a single point mutation
Phenylalkylamines (PAA) usually known for their action on L‐type Ca2+ channels potently block the C‐type inactivating lymphocyte Kv1.3 channel resulting in inhibition of activation of T lymphocytes. In order to design PAAs blocking Kv1.3 specifically over L‐type Ca2+ channels, we investigated the state‐dependent manner of mKv1.3 block by the PAA verapamil. Verapamil seems to have access to the open state (OB) and, once bound to the channel, the channel‐verapamil complex is absorbed into a slowly recovering state. This state was proposed to be the inactivated blocked state (IB). Here we present a quantitative description of the transition into this state and provide evidence for the IB state through experiments with an inactivation lacking mutant channel. Since the inactivated state cannot be reached in this case the IB state cannot be reached either. We show that the transition OB→IB is accelerated by verapamil most likely through a mechanism involving the reduction of [K+] at an inactivation modulating low affinity binding site for K+ at the outer vestibule. Measurements of the voltage‐dependence of the off‐rate constants for verapamil suggest that verapamil can reach the channel in its neutral form and might get partially protonated while bound. Thus only those verapamil molecules that are protonated can more easily dissociate at hyperpolarizing voltages. Since open block kinetics were shown to be similar for wild type mKv1.3 and the H404T mutant mKv1.3 channel, and since the block of the H404T mutant channels by verapamil could be described exactly by a simple three‐state open block model, the mutant channel could serve as a screening channel to determine open block affinities of new PAA derivatives in high through‐put experiments. British Journal of Pharmacology (2000) 131, 1275–1284; doi:10.1038/sj.bjp.0703723
- 1 July 1999
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (5) , 1065-1074
The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel
We investigated the action of the phenylalkylamines verapamil and N‐methyl‐verapamil on the Kv1.3 potassium channel using the whole‐cell configuration of the patch‐clamp technique. Our goal was to identify their binding as a prerequisite for using the phenylalkylamines as small, well‐defined molecular probes, not only to expand the structural findings made with peptide toxins or by crystallization, but also to use them as lead compounds for the generation of more potent and therefore more specific K+ channel modulators. Competition experiments with charybdotoxin, known to interact with external residues of Kv1.3, showed no interaction with verapamil. The internal application of quarternary N‐methyl‐verapamil in combination with verapamil suggested competition for the same internal binding site. Verapamil affinity was decreased 6 fold by a mutation (M395V) in a region of the internal pore which forms part of the internal tetraethylammonium (TEA+) binding site, although mutations at neighbouring residues (T396 and T397) were without effect. Modification of C‐type inactivation by mutations in the internal pore suggest that this region participates in the inactivation process. The action of phenylalkylamines and local anaesthetics on L‐type Ca2+ channels and Na+ channels, respectively, and verapamil on Kv1.3 indicate very similar blocking mechanisms. This might allow the use of these compounds as molecular probes to map the internal vestibule of all three channel types. British Journal of Pharmacology (1999) 127, 1065–1074; doi:10.1038/sj.bjp.0702599
- 1 July 1999
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (5) , 1065-1074
The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel
We investigated the action of the phenylalkylamines verapamil and N‐methyl‐verapamil on the Kv1.3 potassium channel using the whole‐cell configuration of the patch‐clamp technique. Our goal was to identify their binding as a prerequisite for using the phenylalkylamines as small, well‐defined molecular probes, not only to expand the structural findings made with peptide toxins or by crystallization, but also to use them as lead compounds for the generation of more potent and therefore more specific K+ channel modulators. Competition experiments with charybdotoxin, known to interact with external residues of Kv1.3, showed no interaction with verapamil. The internal application of quarternary N‐methyl‐verapamil in combination with verapamil suggested competition for the same internal binding site. Verapamil affinity was decreased 6 fold by a mutation (M395V) in a region of the internal pore which forms part of the internal tetraethylammonium (TEA+) binding site, although mutations at neighbouring residues (T396 and T397) were without effect. Modification of C‐type inactivation by mutations in the internal pore suggest that this region participates in the inactivation process. The action of phenylalkylamines and local anaesthetics on L‐type Ca2+ channels and Na+ channels, respectively, and verapamil on Kv1.3 indicate very similar blocking mechanisms. This might allow the use of these compounds as molecular probes to map the internal vestibule of all three channel types. British Journal of Pharmacology (1999) 127, 1065–1074; doi:10.1038/sj.bjp.0702599
- 1 January 1998
- Published by Wiley in The Journal of Physiology
- Vol. 506 (2) , 291-301
Regulation of mammalian Shaker‐related K+ channels: evidence for non‐conducting closed and non‐conducting inactivated states
1. Using the whole-cell recording mode we have characterized two non-conducting states in mammalian Shaker-related voltage-gated K+ channels induced by the removal of extracellular potassium, K+o. 2. In the absence of K+o, current through Kv1.4 was almost completely abolished due to the presence of a charged lysine residue at position 533 at the entrance to the pore. Removal of K+o had a similar effect on current through Kv1.3 when the histidine at the homologous position (H404) was protonated (pH 6.0). Channels containing uncharged residues at the corresponding position (Kv1.1: Y; Kv1.2: V) did not exhibit this behaviour. 3. To characterize the nature of the interaction between Kv1.3 and K+o concentration ([K+]o), we replaced H404 with amino acids of different character, size and charge. Substitution of hydrophobic residues (A, V and L) either in all four subunits or in only two subunits in the tetramer made the channel insensitive to the removal of K+o, possibly by stabilizing the channel complex. Replacement of H404 with the charged residue arginine, or the polar residue asparagine, enhanced the sensitivity of the channel to 0 mM K+o, possibly by making the channel unstable in the absence of K+o. Mutation at a neighbouring position (400) had a similar effect. 4. The effect of removing K+o on current amplitude does not seem to be correlated with the rate of C-type inactivation since the slowly inactivating G380F mutant channel exhibited a similar [K+]o dependence as the wild-type Kv1.3 channel. 5. CP-339,818, a drug that recognizes only the inactivated conformation of Kv1.3, could not block current in the absence of K+o unless the channels were inactivated through depolarizing pulses. 6. We conclude that removal of K+o induces the Kv1.3 channel to transition to a non-conducting 'closed' state which can switch into a non-conducting 'inactivated' state upon depolarization.
- 1 January 1998
- Published by Wiley in The Journal of Physiology
- Vol. 506 (2) , 291-301
Regulation of mammalian Shaker‐related K+ channels: evidence for non‐conducting closed and non‐conducting inactivated states
1. Using the whole-cell recording mode we have characterized two non-conducting states in mammalian Shaker-related voltage-gated K+ channels induced by the removal of extracellular potassium, K+o. 2. In the absence of K+o, current through Kv1.4 was almost completely abolished due to the presence of a charged lysine residue at position 533 at the entrance to the pore. Removal of K+o had a similar effect on current through Kv1.3 when the histidine at the homologous position (H404) was protonated (pH 6.0). Channels containing uncharged residues at the corresponding position (Kv1.1: Y; Kv1.2: V) did not exhibit this behaviour. 3. To characterize the nature of the interaction between Kv1.3 and K+o concentration ([K+]o), we replaced H404 with amino acids of different character, size and charge. Substitution of hydrophobic residues (A, V and L) either in all four subunits or in only two subunits in the tetramer made the channel insensitive to the removal of K+o, possibly by stabilizing the channel complex. Replacement of H404 with the charged residue arginine, or the polar residue asparagine, enhanced the sensitivity of the channel to 0 mM K+o, possibly by making the channel unstable in the absence of K+o. Mutation at a neighbouring position (400) had a similar effect. 4. The effect of removing K+o on current amplitude does not seem to be correlated with the rate of C-type inactivation since the slowly inactivating G380F mutant channel exhibited a similar [K+]o dependence as the wild-type Kv1.3 channel. 5. CP-339,818, a drug that recognizes only the inactivated conformation of Kv1.3, could not block current in the absence of K+o unless the channels were inactivated through depolarizing pulses. 6. We conclude that removal of K+o induces the Kv1.3 channel to transition to a non-conducting 'closed' state which can switch into a non-conducting 'inactivated' state upon depolarization.